Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01416467 · ClinicalTrials.gov registry record
Characterization of the Patient Population With Galactosialidosis
A clinical trial, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- 3
- Enrollment target
NCT01416467 is a clinical trial that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 3 participants.
The verdict
NCT01416467 has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- 3 participants
- Enrollment target
Study Summary
The late infantile form of galactosialidosis is potentially amenable to treatment by gene transfer with an adeno-associated viral vector encoding Protective Protein Cathepsin A (PPCA) or by infusion of purified protein. The published literature contains limited descriptions of the disease nor is it known how many patients with the disorder are potentially available for protocol enrollment. This preliminary study is designed to define the demographics and clinical characteristics of the patient population with galactosialidosis. Individuals for whom DNA diagnosis has been performed at St. Jude Children's Research Hospital (SJCRH) will be contacted telephonically to learn their current status. In addition, a letter requesting information regarding patients with galactosialidosis will be sent to all pediatric geneticists throughout the United States. Selected physicians with expertise in lysosomal storage diseases throughout the world will also be contacted. Foundations and Associations for the lysosomal storage disorders will also be contacted in an effort to identify additional potential patients with galactosialidosis. The information to be collected in this preliminary study will facilitate development of specific eligibility criteria for future therapeutic studies.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2012-02-08 |
| Est. Completion | 2012-04-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01416467
The ClinicalTrials.gov registry entry for NCT01416467 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01416467 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01416467 about?
NCT01416467 is a clinical study titled "Characterization of the Patient Population With Galactosialidosis". The late infantile form of galactosialidosis is potentially amenable to treatment by gene transfer with an adeno-associated viral vector encoding Protective Protein Cathepsin A (PPCA) or by infusion of purified protein. The published literature contains limited descriptions of the disease nor is it ...
What is the current status of trial NCT01416467?
This trial is currently completed. The enrollment target is 3 participants. The study started on 2012-02-08. Estimated completion is 2012-04-12.
Who is sponsoring clinical trial NCT01416467?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.